Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Nuo Therapeutics, Inc.AURX · Entity 7149 | 10% owner | July 30, 2025 | August 01, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Nuo Therapeutics, Inc.
Report date July 30, 2025 · Filed August 01, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,570,833 |
Reported balance
After 2025-07-30 transaction · row 1
1 source rowRow 1 · 2025-07-30 · Purchase · Acquired 133,333 · Balance 11,570,833 |
| Common StockSEC Table I · non-derivative | IndirectShares held in separate trusts for the benefit of children of the Reporting Person | 3,365 |
Reported balance
Holding disclosure · report date 2025-07-30 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 3,365 F1: The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 30, 2025 Filed Aug 1, 2025 18:03 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | PurchaseCommon Stock | 133,333 | $1.50 | $199,999.50 |
DisclosureSEC source: 0001437749-25-024427 · rdgdoc.xml · nonDerivative · entry 1 SHEEDY CHARLES E · CIK 0001005483 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,570,833 Read SEC document |
| September 18, 2024 Filed Sep 19, 2024 20:21 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | PurchaseCommon Stock | 125,000 | $0.75 | $93,750.00 |
DisclosureSEC source: 0001437749-24-029634 · rdgdoc.xml · nonDerivative · entry 1 SHEEDY CHARLES E · CIK 0001005483 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,437,500 Read SEC document |
| May 20, 2024 Filed May 21, 2024 15:14 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | PurchaseCommon Stock | 100,000 | $0.75 | $75,000.00 |
DisclosureSEC source: 0001437749-24-017815 · rdgdoc.xml · nonDerivative · entry 1 SHEEDY CHARLES E · CIK 0001005483 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,312,500 Read SEC document |
| December 19, 2023 Filed Dec 20, 2023 14:05 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | PurchaseCommon Stock | 150,000 | $0.50 | $75,000.00 |
DisclosureSEC source: 0001437749-23-034984 · rdgdoc.xml · nonDerivative · entry 1 SHEEDY CHARLES E · CIK 0001005483 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,212,500 Read SEC document |
| August 01, 2023 Filed Aug 4, 2023 13:41 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | PurchaseCommon Stock | 62,500 | $2.00 | $125,000.00 |
DisclosureSEC source: 0001437749-23-022109 · rdgdoc.xml · nonDerivative · entry 1 SHEEDY CHARLES E · CIK 0001005483 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,062,500 Read SEC document |
| April 29, 2022 Filed May 2, 2022 12:21 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | PurchaseCommon Stock | 804,868 | $1.00 | $804,868.00 |
DisclosureSEC source: 0001437749-22-010378 · rdgdoc.xml · nonDerivative · entry 1 SHEEDY CHARLES E · CIK 0001005483 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000,000 Read SEC document |
| December 30, 2021 Filed Apr 26, 2022 21:28 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | OtherWarrants to purchase Common Stock · Derivative | 1,431,615 | $0.00 Strike: $0.20 | $0.00 |
DisclosureSEC source: 0001437749-22-009785 · rdgdoc.xml · derivative · entry 5 SHEEDY CHARLES E · CIK 0001005483 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,431,615 shares Expires 2022-01-31 F3 · price: The reported transactions relate to an amendment of the exercise price of outstanding warrants contingent upon the Reporting Person exercising the warrants. As a result, the outstanding warrants were deemed cancelled and modified warrants were issued for the same number of shares of Common Stock, but with a reduced exercise price. Read SEC document |
| December 30, 2021 Filed Apr 26, 2022 21:28 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | OtherCommon Stock | 1,431,615 | $0.20 | $286,323.00 |
DisclosureSEC source: 0001437749-22-009785 · rdgdoc.xml · nonDerivative · entry 1 SHEEDY CHARLES E · CIK 0001005483 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,195,132 Read SEC document |
| December 01, 2021 Filed Apr 26, 2022 21:28 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | OtherWarrants to purchase Common Stock · Derivative | 1,431,615 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001437749-22-009785 · rdgdoc.xml · derivative · entry 4 SHEEDY CHARLES E · CIK 0001005483 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,431,615 shares Expires 2025-10-05 F4 · kind: Cancelled in accordance with Warrant Modification Agreement dated as of 12/01/21 F3 · price: The reported transactions relate to an amendment of the exercise price of outstanding warrants contingent upon the Reporting Person exercising the warrants. As a result, the outstanding warrants were deemed cancelled and modified warrants were issued for the same number of shares of Common Stock, but with a reduced exercise price. Read SEC document |
| December 01, 2021 Filed Apr 26, 2022 21:28 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | OtherWarrants to purchase Common Stock · Derivative | 1,431,615 | $0.00 Strike: $0.20 | $0.00 |
DisclosureSEC source: 0001437749-22-009785 · rdgdoc.xml · derivative · entry 3 SHEEDY CHARLES E · CIK 0001005483 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,431,615 Underlying: Common Stock · 1,431,615 shares Expires 2022-01-31 F2 · kind: Acquired in accordance with Warrant Modification Agreement dated as of 12/01/21 F3 · price: The reported transactions relate to an amendment of the exercise price of outstanding warrants contingent upon the Reporting Person exercising the warrants. As a result, the outstanding warrants were deemed cancelled and modified warrants were issued for the same number of shares of Common Stock, but with a reduced exercise price. Read SEC document |
| October 05, 2020 Filed Apr 26, 2022 21:24 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | OtherWarrants to purchase Common Stock · Derivative | 165,000 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001437749-22-009782 · rdgdoc.xml · derivative · entry 5 SHEEDY CHARLES E · CIK 0001005483 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 165,000 shares Expires not disclosed F6 · shares: Cancelled in accordance with Recapitalization Agreement Schedule dated as of October 5, 2020 F5 · price: The reported transactions involved a recapitalization resulting in the deemed cancellation of the "old" warrants and the deemed grant of "replacement" warrants. F7 · derivative.exercise_date: Originally exercisable on 11/15/19 and 12/06/19, with expirations of 11/15/24 and 12/06/24, respectively, for 15,000 shares and 150,000 shares F7 · derivative.expiration_date: Originally exercisable on 11/15/19 and 12/06/19, with expirations of 11/15/24 and 12/06/24, respectively, for 15,000 shares and 150,000 shares Read SEC document |
| October 05, 2020 Filed Apr 26, 2022 21:24 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | OtherWarrants to purchase Common Stock · Derivative | 1,431,615 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001437749-22-009782 · rdgdoc.xml · derivative · entry 4 SHEEDY CHARLES E · CIK 0001005483 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,431,615 Underlying: Common Stock · 1,431,615 shares Expires 2025-10-05 F4 · shares: Acquired in accordance with Recapitalization Agreement Schedule dated as of October 5, 2020 F5 · price: The reported transactions involved a recapitalization resulting in the deemed cancellation of the "old" warrants and the deemed grant of "replacement" warrants. Read SEC document |
| October 05, 2020 Filed Apr 26, 2022 21:24 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | PurchaseCommon Stock | 175,000 | $0.40 | $70,000.00 |
DisclosureSEC source: 0001437749-22-009782 · rdgdoc.xml · nonDerivative · entry 2 SHEEDY CHARLES E · CIK 0001005483 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,763,517 F2 · kind: Purchase shares acquired in accordance with Recapitalization Agreement Schedule dated as of October 5, 2020 Read SEC document |
| October 05, 2020 Filed Apr 26, 2022 21:24 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | OtherCommon Stock | 302,205 | $0.40 | $120,882.00 |
DisclosureSEC source: 0001437749-22-009782 · rdgdoc.xml · nonDerivative · entry 1 SHEEDY CHARLES E · CIK 0001005483 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,588,517 F1 · kind: Conversion shares acquired in accordance with Recapitalization Agreement Schedule dated as of October 5, 2020 Read SEC document |
| December 06, 2019 Filed Apr 26, 2022 21:21 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | PurchaseWarrants to purchase Common Stock · Derivative | 150,000 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001437749-22-009779 · rdgdoc.xml · derivative · entry 2 SHEEDY CHARLES E · CIK 0001005483 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,000 Underlying: Common Stock · 150,000 shares Expires 2024-12-06 F1 · kind: Acquired in connection with Note Purchase Agreement dated as of November 15, 2019 Read SEC document |
| November 15, 2019 Filed Apr 26, 2022 21:21 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | PurchaseWarrants to purchase Common Stock · Derivative | 15,000 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001437749-22-009779 · rdgdoc.xml · derivative · entry 1 SHEEDY CHARLES E · CIK 0001005483 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2024-11-15 F1 · kind: Acquired in connection with Note Purchase Agreement dated as of November 15, 2019 Read SEC document |
| August 10, 2017 Filed Aug 14, 2017 15:25 UTC | Nuo Therapeutics, Inc. AURX · Entity 7149 | PurchaseCommon Stock | 5,220,000 | $0.22 | $1,159,884.00 |
DisclosureSEC source: 0000899243-17-020218 · doc4.xml · nonDerivative · entry 1 SHEEDY CHARLES E · CIK 0001005483 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,286,312 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.